Generic antifungal drug put to the test in healthy volunteers
NCT ID NCT06977490
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study checked if a new version of the antifungal medicine amphotericin B liposome works the same as the original. 42 healthy adults received a single dose of each version at different times. The goal was to see if the two versions are bioequivalent, meaning they are absorbed and processed by the body similarly. This is a standard step to ensure generic medicines are as safe and effective as the brand-name drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE FUNGAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinan Central Hospital, No.105, Jiefang Road,
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.